Lineage Cell Therapeutics, Inc. (TLV:LCTX)
Israel · Delayed Price · Currency is ILS · Price in ILA 423.40
+3.30 (0.79%)
Sep 11, 2025, 5:24 PM IDT
Lineage Cell Therapeutics Market Cap
Lineage Cell Therapeutics has a market cap or net worth of 1.02 billion as of September 12, 2025. Its market cap has increased by 62.04% in one year.
Market Cap
1.02B
Enterprise Value
882.99M
Revenue
36.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
423.40
Market Cap Chart
Since May 1, 1992, Lineage Cell Therapeutics's market cap has increased from 49.45M to 1.02B, an increase of 1,965.09%. That is a compound annual growth rate of 9.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 1.02B | 153.13% |
| Dec 31, 2024 | 403.42M | -41.27% |
| Dec 29, 2023 | 686.90M | -1.77% |
| Dec 30, 2022 | 699.29M | -45.56% |
| Dec 31, 2021 | 1.28B | 51.35% |
| Dec 31, 2020 | 848.66M | 84.29% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 76.30B |
| Danel (Adir Yeoshua) | 2.90B |
| Kamada | 1.36B |
| BrainsWay | 991.19M |
| SofWave Medical | 979.20M |
| Bait Bakfar | 979.07M |
| Novolog (Pharm-Up 1966) | 757.12M |
| Ilex Medical | 708.32M |